Genmab named Judith Klimovsky as chief development officer. She has had a distinguished career in drug development, most recently serving as senior vice president and global head, oncology clinical development, at Novartis.
TSO3 appointed Mark Pasmore as vice president of research and development. He previously held leadership positions in biofilms, sterilization, sterility assurance and microbial control for pharmaceuticals and medical devices for Baxter Healthcare and STERIS.
Integrity Applications has named Sami Sassoun as chief financial officer. He joins the company from Bedrock Enterprises. Integrity’s former CFO, Eran Hertz, is expected to remain with the company for an undetermined period to assist in the transition.